ILBS has achieved the distinction of being a World Health Organization Collaborating Centre (WHOCC) on liver disease and second on viral hepatitis.
The collaboration between ILBS and WHO would enable systematic collection and analysis of community and hospital-based data on hepatitis A, B, C and E, including various aspects of transmission, prevention, and treatment specific to low resource settings in India. Such data would help WHO in developing guidelines and recommendations on these aspects of diseases and formulate policies accordingly. The collaborating centre will also serve as a resource center for training of different categories of healthcare workers in relation to viral hepatitis and liver diseases.
TOR 1: To assist WHO with measurement of mortality from hepatitis and other causes of chronic liver diseases as to evaluate the impact of implementation of the GPW13 at country level.
TOR 2: To build capacity among healthcare workers on hepatitis prevention, diagnosis and treatment.
TOR 3: To assist WHO in the implementation of the assessment of Hepatitis B & C testing kits.
Call us now
Drop us an email
Monday to Saturday